Methicillin-resistant Staphylococcus aureus

AS Lee, H De Lencastre, J Garau… - Nature reviews Disease …, 2018 - nature.com
Since the 1960s, methicillin-resistant Staphylococcus aureus (MRSA) has emerged,
disseminated globally and become a leading cause of bacterial infections in both health …

Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management

SYC Tong, JS Davis, E Eichenberger… - Clinical microbiology …, 2015 - Am Soc Microbiol
Staphylococcus aureus is a major human pathogen that causes a wide range of clinical
infections. It is a leading cause of bacteremia and infective endocarditis as well as …

Clinical Impact of Staphylococcus aureus Skin and Soft Tissue Infections

MS Linz, A Mattappallil, D Finkel, D Parker - Antibiotics, 2023 - mdpi.com
The pathogenic bacterium Staphylococcus aureus is the most common pathogen isolated in
skin-and-soft-tissue infections (SSTIs) in the United States. Most S. aureus SSTIs are caused …

[HTML][HTML] Pathogenesis of Staphylococcus aureus abscesses

SD Kobayashi, N Malachowa, FR DeLeo - The American journal of …, 2015 - Elsevier
Staphylococcus aureus causes many types of human infections and syndromes—most
notably skin and soft tissue infections. Abscesses are a frequent manifestation of S. aureus …

Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic

MZ David, RS Daum - Clinical microbiology reviews, 2010 - Am Soc Microbiol
Staphylococcus aureus is an important cause of skin and soft-tissue infections (SSTIs),
endovascular infections, pneumonia, septic arthritis, endocarditis, osteomyelitis, foreign …

Waves of resistance: Staphylococcus aureus in the antibiotic era

HF Chambers, FR DeLeo - Nature reviews microbiology, 2009 - nature.com
Staphylococcus aureus is notorious for its ability to become resistant to antibiotics. Infections
that are caused by antibiotic-resistant strains often occur in epidemic waves that are initiated …

Infection prevention and control guideline for cystic fibrosis: 2013 update

L Saiman, JD Siegel, JJ LiPuma, RF Brown… - Infection Control & …, 2014 - cambridge.org
The 2013 Infection Prevention and Control (IP&C) Guideline for Cystic Fibrosis (CF) was
commissioned by the CF Foundation as an update of the 2003 Infection Control Guideline …

Community-associated meticillin-resistant Staphylococcus aureus

FR DeLeo, M Otto, BN Kreiswirth, HF Chambers - The Lancet, 2010 - thelancet.com
Meticillin-resistant Staphylococcus aureus (MRSA) is endemic in hospitals worldwide, and
causes substantial morbidity and mortality. Health-care-associated MRSA infections arise in …

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and …

C Liu, A Bayer, SE Cosgrove, RS Daum… - Clinical infectious …, 2011 - academic.oup.com
To clarify whether apoptosis is involved in the injury processes induced by autoantibody
against cardiac β1-adrenoceptor, we investigated the biological and apoptotic effects of …

The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis

LJ Shallcross, E Fragaszy, AM Johnson… - The Lancet infectious …, 2013 - thelancet.com
Background Invasive community-onset staphylococcal disease has emerged worldwide
associated with Panton-Valentine leucocidin (PVL) toxin. Whether PVL is pathogenic or an …